First published · Last updated
Beyond CRP and SAA: Proteomics reveals a combined CR2 and VSIG4 signature for severity in influenza and COVID-19 pneumonia
An Elsevier journal article reports that proteomic analysis identified a combined CR2 and VSIG4 biomarker signature associated with severity in influenza and COVID-19 pneumonia. The item is a research publication dated 2026-11-01.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 4/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 2/10
- Urgency
- 2/10
Why it matters
A proteomic signature linked to disease severity could be relevant to medical research and clinical assessment of pneumonia.

